{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:40Z","timestamp":1788484420902,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218773","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:25:45Z","timestamp":1785799545000},"page":"218773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Induction of cuproptosis via targeting mitochondrial metabolism using dPTBD with potent therapeutic activity against KRAS-driven cancer"],"prefix":"10.1016","volume":"658","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4029-5968","authenticated-orcid":false,"given":"Yichen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-8243","authenticated-orcid":false,"given":"Shijun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-9152","authenticated-orcid":false,"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218773_bib1","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218773_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamaoncol.2016.0405","article-title":"Prognostic and predictive value in KRAS in non\u2013small-cell lung cancer: a review","volume":"2","author":"Wood","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218773_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218773_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218773_bib5","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for lung cancers with KRAS P. G12C mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218773_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2204619","article-title":"Adagrasib in non\u2013small-cell lung cancer harboring a KRAS G12C mutation","volume":"387","author":"J\u00e4nne","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218773_bib7","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor","volume":"65","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218773_bib8","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1021\/jacs.2c05377","article-title":"Chemoselective covalent modification of K-Ras (G12R) with a small molecule electrophile","volume":"144","author":"Zhang","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2026.218773_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41589-022-01065-9","article-title":"Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras (G12S)","volume":"18","author":"Zhang","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218773_bib10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ccell.2024.06.001","article-title":"Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer","volume":"42","author":"Zhou","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218773_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.21037\/tlcr-22-639","article-title":"Targeted therapies for KRAS-Mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review","volume":"12","author":"Santarpia","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.canlet.2026.218773_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218773_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","article-title":"The current state of the art and future trends in RAS-targeted cancer therapies","volume":"19","author":"Punekar","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218773_bib14","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3390\/cancers13112541","article-title":"KRAS G12C mutations in NSCLC: from target to resistance","volume":"13","author":"Addeo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218773_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade3816","article-title":"Acquired resistance to KRAS G12C small-molecule inhibitors via genetic\/nongenetic mechanisms in lung cancer","volume":"9","author":"Mohanty","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218773_bib16","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1158\/1078-0432.CCR-17-3438","article-title":"Assessing therapeutic efficacy of MEK inhibition in a KrasG12C-driven mouse model of lung cancer","volume":"24","author":"Li","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218773_bib17","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218773_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031518","article-title":"Synthetic lethal vulnerabilities in kras-mutant cancers","volume":"8","author":"Aguirre","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.canlet.2026.218773_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17549-y","article-title":"Copper bioavailability is a KRAS-Specific vulnerability in colorectal cancer","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218773_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2011.145","article-title":"K-ras G12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis","volume":"22","author":"Hu","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218773_bib21","article-title":"Cooperativity of oncogenic K-ras and downregulated p16\/INK4A in human pancreatic tumorigenesis","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218773_bib22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1530-0277.2006.00224.x","article-title":"Time course of attention for alcohol cues in abstinent alcoholic patients: the role of initial orienting","volume":"30","author":"No\u00ebl","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.canlet.2026.218773_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1021\/pr049754t","article-title":"Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra","volume":"4","author":"Chen","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2026.218773_bib24","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1038\/ncomms8227","article-title":"A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours","volume":"6","author":"Kalathur","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218773_bib25","doi-asserted-by":"crossref","first-page":"16375","DOI":"10.1073\/pnas.1113554108","article-title":"Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines","volume":"108","author":"Somwar","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.canlet.2026.218773_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218773_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0076-6879(90)86093-B","article-title":"Role of free radicals and catalytic metal ions in human disease: an overview","volume":"186","author":"Halliwell","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.canlet.2026.218773_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-015-1579-5","article-title":"Redox- and non-redox-metal-induced formation of free radicals and their role in human disease","volume":"90","author":"Valko","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.canlet.2026.218773_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","article-title":"Targeting cuproplasia and cuproptosis in cancer","volume":"21","author":"Tang","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218773_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jare.2024.10.026","article-title":"Multiple roles of p53 in cancer development: regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms","volume":"75","author":"Wang","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.canlet.2026.218773_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archneur.1991.00530130050019","article-title":"Initial therapy of patients with Wilson's disease with tetrathiomolybdate","volume":"48","author":"Brewer","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.canlet.2026.218773_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1020503410377","article-title":"Investigating the mechanism of electron transfer to the binuclear center in Cu-heme oxidases","volume":"30","author":"Brunori","year":"1998","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.canlet.2026.218773_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/iub.50","article-title":"Mitochondrial copper metabolism and delivery to cytochrome c oxidase","volume":"60","author":"Horn","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2026.218773_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2013.06.008","article-title":"Regulation and function of pyruvate kinase M2 in cancer","volume":"339","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218773_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"150","author":"Yang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218773_bib36","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.179.4078.1140","article-title":"Menkes' kinky hair disease: further definition of the defect in copper transport","volume":"179","author":"Danks","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218773_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1079\/PNS19620007","article-title":"The metabolism of copper and Wilson's disease","volume":"21","author":"Cumings","year":"1962","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.canlet.2026.218773_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/srep00011","article-title":"Mechanism of copper (II)-induced misfolding of Parkinson's disease protein","volume":"1","author":"Rose","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218773_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.ede.0000209454.41466.b7","article-title":"Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality","volume":"17","author":"Leone","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.canlet.2026.218773_bib40","first-page":"981","article-title":"Copper, zinc, and iron in normal and leukemic lymphocytes from children","volume":"46","author":"Carpentieri","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218773_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/BTER:114:1:41","article-title":"Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia","volume":"114","author":"Zuo","year":"2006","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.canlet.2026.218773_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/BTER:89:1:1","article-title":"Serum and tissue trace elements in patients with breast cancer in Taiwan","volume":"89","author":"Kuo","year":"2002","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.canlet.2026.218773_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2176\/nmc.35.133","article-title":"Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion","volume":"35","author":"Yoshida","year":"1995","journal-title":"Neurol. Med.-Chir."},{"key":"10.1016\/j.canlet.2026.218773_bib44","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1158\/0008-5472.CAN-04-3577","article-title":"Anticancer activity of the antibiotic clioquinol","volume":"65","author":"Ding","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218773_bib45","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218773_bib46","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218773_bib47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","article-title":"A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer","volume":"20","author":"Nechushtan","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218773_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08242-4","article-title":"A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker","volume":"21","author":"Kelley","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218773_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.734853","article-title":"Disulfiram improves the anti-PD-1 therapy efficacy by regulating PD-L1 expression via epigenetically reactivation of IRF7 in triple negative breast cancer","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218773_bib50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","article-title":"Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma","volume":"31","author":"O'Day","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218773_bib51","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0153","article-title":"The pervasiveness of macropinocytosis in oncological malignancies","volume":"374","author":"Commisso","year":"2019","journal-title":"Philos. Trans. R. Soc. B"},{"issue":"7","key":"10.1016\/j.canlet.2026.218773_bib52","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/MCB.05722-11","article-title":"A novel role for copper in Ras\/mitogen-activated protein kinase signaling","volume":"32","author":"Turski","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218773_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218773_bib54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10147-017-1156-4","article-title":"Targeting metabolic reprogramming in KRAS-driven cancers","volume":"22","author":"Kawada","year":"2017","journal-title":"Int. J. Clin. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:44:27Z","timestamp":1788482667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":54,"alternative-id":["S0304383526005379"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218773","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of cuproptosis via targeting mitochondrial metabolism using dPTBD with potent therapeutic activity against KRAS-driven cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218773"}}